#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Rare disease

Oropharyngeal squamous cell carcinoma

6 clinical trials

Quick filters

Clinical trials for Oropharyngeal squamous cell carcinoma

6 trials across Europe

See all trials →

Quick filters

6 Clinical trials

Squamous cell carcinoma of the oral cavity+4

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Afatinib
Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Contact Research Centre

Oropharyngeal squamous cell carcinoma

Not recruiting

Registered drugNo placebo

Study on Reducing Treatment Intensity for Patients with HPV-Positive Oropharyngeal Cancer Using Cisplatin and Carboplatin

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Cardiff University

Contact Research Centre

Squamous cell carcinoma of the oral cavity+3

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lenvatinib
Sponsor:Universitaet Des Saarlandes

Contact Research Centre

Oropharyngeal squamous cell carcinoma

Not recruiting

Registered drugNo placebo

Study on Reducing Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Using Cisplatin for Patients with Squamous Cell Carcinoma

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Vychodoslovensky Onkologicky Ustav a.s.

Contact Research Centre

Oropharyngeal squamous cell carcinoma

Not recruiting

Registered drugNo placebo

Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Fondazione GONO Plus

Contact Research Centre

Oropharyngeal squamous cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

See all trials →

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.